{
    "2018-01-14": [
        [
            {
                "time": "",
                "original_text": "医药生物行业周报：行业趋势明确看好龙头和创新",
                "features": {
                    "keywords": [
                        "医药",
                        "生物",
                        "行业趋势",
                        "龙头",
                        "创新"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "恒瑞医药(600276)重大事件快评：海外合作深化创新药国际化进程",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "海外合作",
                        "创新药",
                        "国际化"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【华创医药周报201803】关注大病种领域用药格局的变化与投资机会",
                "features": {
                    "keywords": [
                        "华创医药",
                        "周报",
                        "大病种",
                        "用药格局",
                        "投资机会"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "恒瑞医药：海外合作深化创新药国际化进程 买入评级",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "海外合作",
                        "创新药",
                        "国际化",
                        "买入评级"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医疗保健：看好龙头和创新 荐17股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "龙头",
                        "创新",
                        "荐股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗保健"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}